Ruthenium-106 Plaque Brachytherapy in the Primary Management of Ocular Medulloepithelioma
Daniel Poon(Rapt Therapeutics (United States)), Mandeep S. Sagoo(Moorfields Eye Hospital NHS Foundation Trust), Ehud Reich(Royal London Hospital), Judith Kingston(Great Ormond Street Hospital), John L. Hungerford(Institute of Ophthalmology), Victoria M. Smith(Royal London Hospital), M. Ashwin Reddy(University College London)
Cited by 18
Related Papers
Attitudes and perceptions of UK medical students towards artificial intelligence and radiology: a multicentre survey
|Insights into Imaging|2020|492
Food, Shelter and Safety Needs Motivating Homeless Persons' Visits to an Urban Emergency Department
|Annals of Emergency Medicine|2008|100
c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma
|British Journal of Ophthalmology|1999|99
A Missense Mutation in the MBTPS2 Gene Underlies the X-Linked Form of Olmsted Syndrome
|Journal of Investigative Dermatology|2012|57
Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma
|ACS Medicinal Chemistry Letters|2015|54